Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond

It remains a challenge for the effective treatment of neuroinflammatory disease, including multiple sclerosis (MS), stroke, epilepsy, and Alzheimer’s and Parkinson’s disease. The voltage-gated potassium Kv1.3 channel is of interest, which is considered as a novel therapeutic target for treating neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoli, Li, Guoyi, Guo, Jingkang, Zhang, Zhiping, Zhang, Shuzhang, Zhu, Yudan, Cheng, Jiwei, Yu, Lu, Ji, Yonghua, Tao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971160/
https://www.ncbi.nlm.nih.gov/pubmed/31992966
http://dx.doi.org/10.3389/fnins.2019.01393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971160/
https://www.ncbi.nlm.nih.gov/pubmed/31992966
http://dx.doi.org/10.3389/fnins.2019.01393

Ejemplares similares